Greater weight loss with RYGB in obese with T2DM at three years

Greater weight loss with RYGB in obese with T2DM at three years
(HealthDay)—For obese adults with type 2 diabetes, Roux-en-Y gastric bypass (RYGB) surgery is associated with greater weight loss, lower hemoglobin A1c (HbA1c), and reduced cardiovascular risk compared with intensive medical diabetes and weight management (IMWM), according to a study published online Feb. 6 in Diabetes Care.

Donald C. Simonson, M.D., M.P.H., Sc.D., from Brigham and Women's Hospital in Boston, and colleagues randomized 38 obese patients with type 2 diabetes to laparoscopic RYGB (19 patients) or IMWM (19 patients). The authors examined changes in weight, HbA1c, , and self-reported health status.

The researchers found that, compared with the IMWM group, the RYGB group had greater weight loss (mean, −24.9 versus −5.2 kg) and lowering of HbA1c (−1.79 versus −0.39 percent) after three years. The RYGB group had more favorable changes in cardiometabolic risk for and stroke than the IMWM group. After RYGB there was more improvement in the Impact of Weight on Quality of Life (IWQOL) instrument, mainly due to subscales of physical function, self-esteem, and work performance. In both groups there was improvement in the 36-Item Short Form (SF-36) survey and the Problem Areas in Diabetes (PAID) questionnaire scores, with no difference between treatments. Improvement in overall quality of life was more strongly associated with loss than improved HbA1c and was manifest by greater improvements in IWQOL than with PAID or SF-36.

"Our study adds to a growing body of work showing metabolic and cardiovascular benefits of RYGB," the authors write.

Several authors disclosed financial ties to the pharmaceutical, medical device, and nutrition industries, which also provided funding for the study.


Explore further

Metabolic benefit same with similar weight loss after surgery

More information: Abstract/Full Text (subscription or payment may be required)

Copyright © 2018 HealthDay. All rights reserved.

Citation: Greater weight loss with RYGB in obese with T2DM at three years (2018, February 14) retrieved 23 January 2019 from https://medicalxpress.com/news/2018-02-greater-weight-loss-rygb-obese.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
10 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more